These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33129610)

  • 1. India's cost-effective COVID-19 vaccine development initiatives.
    Chakraborty C; Agoramoorthy G
    Vaccine; 2020 Nov; 38(50):7883-7884. PubMed ID: 33129610
    [No Abstract]   [Full Text] [Related]  

  • 2. Behind Cuba's successful pandemic response.
    Burki T
    Lancet Infect Dis; 2021 Apr; 21(4):465-466. PubMed ID: 33773131
    [No Abstract]   [Full Text] [Related]  

  • 3. India's DNA COVID vaccine is a world first - more are coming.
    Mallapaty S
    Nature; 2021 Sep; 597(7875):161-162. PubMed ID: 34475553
    [No Abstract]   [Full Text] [Related]  

  • 4. Developing and sustaining India's capacity for preclinical drug discovery.
    Lewis DI; Patel BK; Kumar BD; Medhi B
    Indian J Pharmacol; 2018; 50(5):225-226. PubMed ID: 30636824
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 vaccine: Challenges in developing countries and India's initiatives.
    Chakraborty C; Ranjan Sharma A; Bhattacharya M; Lee SS; Agoramoorthy G
    Infez Med; 2021 Mar; 29(1):165-166. PubMed ID: 33664189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis.
    Bloom DE; Cadarette D; Ferranna M; Hyer RN; Tortorice DL
    Health Aff (Millwood); 2021 Mar; 40(3):410-418. PubMed ID: 33539191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. India's growing clinical research sector: opportunity for global companies.
    Varawalla N
    IDrugs; 2007 Jun; 10(6):391-4. PubMed ID: 17642002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study.
    Gouglas D; Thanh Le T; Henderson K; Kaloudis A; Danielsen T; Hammersland NC; Robinson JM; Heaton PM; Røttingen JA
    Lancet Glob Health; 2018 Dec; 6(12):e1386-e1396. PubMed ID: 30342925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. India's growing participation in global clinical trials.
    Gupta YK; Padhy BM
    Trends Pharmacol Sci; 2011 Jun; 32(6):327-9. PubMed ID: 21489644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. India's drug tests.
    Padma TV
    Nature; 2005 Jul; 436(7050):485. PubMed ID: 16049471
    [No Abstract]   [Full Text] [Related]  

  • 11. India's role in COVID-19 vaccine diplomacy.
    Sharun K; Dhama K
    J Travel Med; 2021 Oct; 28(7):. PubMed ID: 33870417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. India's crusade against COVID-19.
    Madkaikar M; Gupta N; Yadav RM; Bargir UA
    Nat Immunol; 2021 Mar; 22(3):258-259. PubMed ID: 33627877
    [No Abstract]   [Full Text] [Related]  

  • 13. Materials exchange deal meager boost to India's biotech.
    Jayaraman KS
    Nat Biotechnol; 2005 Sep; 23(9):1031. PubMed ID: 16151380
    [No Abstract]   [Full Text] [Related]  

  • 14. Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere.
    Heriot GS; Jamrozik E
    Med J Aust; 2021 Mar; 214(4):150-152.e1. PubMed ID: 33550606
    [No Abstract]   [Full Text] [Related]  

  • 15. Audio Interview: India's Covid-19 Crisis.
    Rubin EJ; Baden LR; Udwadia ZF; Morrissey S
    N Engl J Med; 2021 May; 384(18):e84. PubMed ID: 33951370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fight against COVID-19: market overview and pipeline of ongoing trials].
    Pontremoli R; Richard G; Vuddamalay G; Groux N
    Med Sci (Paris); 2020 Dec; 36(12):1225-1232. PubMed ID: 33211647
    [No Abstract]   [Full Text] [Related]  

  • 17. Access considerations for a COVID-19 vaccine for South Africa.
    Bangalee V; Suleman F
    S Afr Fam Pract (2004); 2020 Oct; 62(1):e1-e4. PubMed ID: 33179954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
    Abbasi J
    JAMA; 2021 Oct; 326(14):1365. PubMed ID: 34636874
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19: vaccination problems.
    Brüssow H
    Environ Microbiol; 2021 Jun; 23(6):2878-2890. PubMed ID: 33928745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India.
    Du Z; Wang L; Bai Y; Feng S; Ramachandran S; Lim WW; Lau EHY; Malani A; Cowling BJ
    Med; 2023 Mar; 4(3):182-190.e3. PubMed ID: 36827972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.